Recent News
Boston Scientific Loses Bid to Reverse $18.5 Million Transvaginal Mesh Lawsuit Verdict
A federal appeals court has upheld the $18.5 million verdict awarded to four women who suffered serious complications following implantation of Boston Scientific Corp.’s Obtryx transvaginal mesh devices. The case was decided in November 2014, after a jury in the … Continue reading
Risperdal Lawsuit News: Thousands of Nursing Home Patients Receiving Dangerous Antipsychotic Medications
A new report from Human Rights Watch contends that thousands of nursing home patients have been prescribed Risperdal or other antipsychotic medications to treat dementia, suggesting that many of these facilities are misusing the potentially dangerous drugs. Antipsychotic medications like … Continue reading
Prilosec Lawsuit News: Federal Court Overseeing Proton Pump Inhibitor Kidney Injury Claims Issues Order Governing Plaintiff Fact Sheets
The federal court overseeing hundreds of proton pump inhibitor lawsuits filed against the manufacturers of Prilosec, Nexium, PrevAcid, Dexilant and Protonix has issued a new Case Management Order governing, among other things, the form, procedure, and schedule for the completion … Continue reading
Federal Judicial Panel Centralizes Onglyza Heart Failure Lawsuits in Eastern District of Kentucky
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has granted a plaintiffs’ motion seeking centralization of all federally-filed Onglyza lawsuits in a single jurisdiction. In an Order dated February 2nd, the Panel transferred all such federal claims to the U.S. … Continue reading
Johnson & Johnson Faces Second Talcum Powder Mesothelioma Trial in New Jersey
Johnson & Johnson is on the defense yet again, as a New Jersey talcum powder lawsuit plaintiff headed to court in a bid to convince a jury that the company’s popular products were responsible for his mesothelioma. The case, which … Continue reading
Limbrel Recall Announced in Wake of FDA Side Effects Warning
Primus Pharmaceuticals, Inc. has agreed to conduct a Limbrel recall, as U.S. health regulators continue to investigate adverse events linking the product to potentially serious side effects, including drug-induced liver injury and hypersensitivity pneumonitis. The U.S. Food & Drug Administration … Continue reading
Federal Court Overseeing 7,500 Taxotere Alopecia Lawsuits Outlines Procedures for Product Identification
The manufacturers of Taxotere and other docetaxel chemotherapy medications continue to face a growing number of product liability lawsuits over their products’ alleged potential to cause permanent or persistent alopecia. According to a Joint Status Report submitted by the parties … Continue reading
Invokana Lawsuit Update: Sales Down 29% Amid Increased Competition, Safety Concern
Growing competition and increased side effect concerns may be weighing on Invokana, the Type 2 diabetes medication marketed by Johnson & Johnson’s Janssen Pharmaceuticals unit. According to Johnson & Johnson’s latest earnings report, fourth quarter 2017 sales of the medication … Continue reading
Federal Court Overseeing Nexium Kidney Failure Lawsuits Sets Date for Science Day
The federal court overseeing hundreds of proton pump inhibitor lawsuits involving serious kidney problems allegedly related to the use of Nexium and similar heartburn drugs has set the date for Science Day. According to a Case Management Order issued on … Continue reading
Follow Us
